Arrastra la portada para recortarla
Pin
However, when HbA1c remains significantly elevated (generally ≥2% above target), or when GLP-1 monotherapy is insufficient, the addition of insulin becomes necessary. The 2026 ADA Standards and international consensus panels now recommend fixed-ratio combinations or the simultaneous initiation of both agents in patients with severe hyperglycemia
Recorta tu avatar
